Subscribe To
Sidechannel reports annual results for 2022
Revenue Increase of 71% over 2021 WORCESTER, Mass., Dec. 20, 2022 (GLOBE NEWSWIRE) — SideChannel (OTCQB:SDCH), a provider of cybersecurity services ...
December 21, 2022, 12:01 am
Biolife solutions to announce preliminary 2022 revenue and introduce 2023 revenue guidance on january 9, 2023
Announcement Precedes Meetings to be Held During the J.P. Morgan Health Care Conference; Updated Investor Presentation ...
December 19, 2022, 8:03 am
Lincoln national: stability with a rebound potential after the contraction
Despite the hampered growth, Lincoln National Corporation demonstrates fundamental stability. Interest ...
December 19, 2022, 6:34 am
My top 7 strong conviction buys for 2023
Investors who avoided losing money this year are positioned to consider stocks that are strong conviction buys. An investment idea earns that level of...
December 15, 2022, 8:11 am
Enersys releases first task force on climate related financial disclosure (tcfd) report, advancing its commitment to climate action
READING, Pa., Dec. 14, 2022 (GLOBE NEWSWIRE) — EnerSys (NYSE: ENS) EnerSys® (NYSE:ENS), the global leader in stored energy solutions for industrial...
December 14, 2022, 9:15 pm
10%-yielding mplx: now is the time to buy
MPLX demonstrates strong operating fundamentals, supported by a high quality asset base. It maintains a...
December 11, 2022, 7:10 am
Tactile systems: lymphedema, airway clearance markets attractive
Tactile Systems Technology, Inc. continues to grow its top line hastily each quarter, which demonstrates...
December 9, 2022, 6:54 pm
Pharvaris shares soar on positive top-line phase 2 data from rapide-1 study as it releases 3q results
Pharvaris (NASDAQ:PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema...
December 8, 2022, 11:34 am
Olema oncology announces op-1250 demonstrates attractive combinability with cdk 4/6 inhibitor palbociclib in phase 1b dose escalation study
OP-1250 in combination with palbociclib was well-tolerated in patients with ER+/HER2- breast cancer, with no dose-limiting toxicities, and no observed...
December 7, 2022, 8:37 pm
Global travel demonstrates resilience against economic slowdown
Despite widespread global inflation, consumers have yet to materially pull back on overall spending, lifting global travel ETFs....
December 7, 2022, 6:59 pm
Target's curbside pickup pact with starbucks demonstrates cross-selling potential
Target is adding Starbucks products to its curbside pickup business. The retail giant stated Wednesday (Nov. 23) that is expanding its rollout of the ...
November 28, 2022, 5:24 pm
Why pampa energía could outperform
Pampa Energía S.A. demonstrates a strong commitment to delivering good results in tandem with rising f...
November 25, 2022, 11:29 pm
Athira pharma to present additional biomarker data from act-ad phase 2 study of fosgonimeton at the 2022 clinical trials on alzheimer's disease (ctad) conference
Fosgonimeton demonstrates improvement on diverse biomarkers of neurodegeneration Fosgonimeton ...
November 21, 2022, 7:00 am
Editas medicine announces clinical data demonstrating proof of concept of edit-101 from phase 1/2 brilliance trial
EDIT-101 demonstrates a favorable safety profile across all dose cohorts Preliminary efficacy signals o...
November 17, 2022, 12:15 pm
Winnebago industries demonstrates strength and resilience of portfolio and presents 2025 strategic plan targets at 2022 investor day
EDEN PRAIRIE, Minn., Nov. 15, 2022 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE:WGO), a leading outdoor lifestyle product manufacturer, today...
November 15, 2022, 9:30 pm
Avadel pharmaceuticals provides corporate update and reports third quarter 2022 financial results
LUMRYZ™ granted tentative approval on July 18, confirming its safety profile and clinical efficacy Final approval decision of LUMRYZ expected by Jun...
November 9, 2022, 12:30 pm
Gilead (gild) breast cancer drug trodelvy improves survival
Gilead (GILD) breast cancer drug Trodelvy demonstrates a statistically significant and clinically meani...
September 8, 2022, 1:32 pm
Uber technologies: don't buy this pullback yet
Our thesis on Uber Technologies, Inc.'s bottom in June has played out accordingly, as it outperformed the broad market significantly since our previou...
September 2, 2022, 8:00 am
This indicator can turn even the most bearish investors into netflix bulls
The stock's performance this year, down over 60%, demonstrates the pessimism surrounding the streaming ...
August 28, 2022, 9:53 am
Dollar general: a discount supermarket in dollar-store clothing
Dollar General's history of replicating trends in adjacent sectors demonstrates that company managers a...
July 18, 2022, 6:51 pm